Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 734, doi. 10.1038/gt.2009.12
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2009 AND VI 16 AND IP 6
Results: 15
1
2
Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 724, doi. 10.1038/gt.2009.13
- By:
- Publication type:
- Article
3
Genetically engineered Newcastle disease virus for malignant melanoma therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 796, doi. 10.1038/gt.2009.14
- By:
- Publication type:
- Article
4
Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 805, doi. 10.1038/gt.2009.20
- By:
- Publication type:
- Article
5
Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 815, doi. 10.1038/gt.2009.28
- By:
- Publication type:
- Article
6
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 716, doi. 10.1038/gt.2009.30
- By:
- Publication type:
- Article
7
Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 776, doi. 10.1038/gt.2009.31
- By:
- Publication type:
- Article
8
Validation of oligonucleotide-mediated gene editing.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 824, doi. 10.1038/gt.2009.32
- By:
- Publication type:
- Article
9
Purification of recombinant baculoviruses for gene therapy using membrane processes.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 766, doi. 10.1038/gt.2009.33
- By:
- Publication type:
- Article
10
High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 788, doi. 10.1038/gt.2009.34
- By:
- Publication type:
- Article
11
Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 746, doi. 10.1038/gt.2009.36
- By:
- Publication type:
- Article
12
In vivo assessment of mutations in OTC for dominant-negative effects following rAAV2/8-mediated gene delivery to the mouse liver.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 820, doi. 10.1038/gt.2009.38
- By:
- Publication type:
- Article
13
Gene therapy for cardiomyocytes, a heart beat away.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 707, doi. 10.1038/gt.2009.40
- By:
- Publication type:
- Article
14
Progress and prospects: Biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 709, doi. 10.1038/gt.2009.42
- By:
- Publication type:
- Article
15
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 757, doi. 10.1038/gt.2009.8
- By:
- Publication type:
- Article